Development Information. 28 4.11. CESSATION OF TRANSCEND BUSINESS ................... 28 ARTICLE 5. MANAGEMENT ........................................ 28 5.1 JOINT DEVELOPMENT TEAM ............................ 28 5.1.1. GENERAL .................................. 28 5.1.2. RESPONSIBILITIES ......................... 28 5.1.3. MEETINGS ................................. 30 5.1.4. REPRESENTATIVES .......................... 30 5.1.5. ACTIONS .................................. 30 5.2. JOINT MARKETING TEAM .............................. 30 5.2.1. GENERAL .................................. 30 5.2.2. MEETINGS ................................. 30 5.2.3. REPRESENTATIVES .......................... 30 5.2.4. ACTIONS .................................. 31 5.3. JOINT STEERING COMMITTEE .......................... 31 5.3.1. GENERAL .................................. 31 5.3.2. CHAIR .................................... 31 5.3.3. MEETINGS ................................. 31 5.3.4. DISAGREEMENTS ............................ 32
Appears in 2 contracts
Sources: Development and License Agreement (Transcend Therapeutics Inc), Development and License Agreement (Transcend Therapeutics Inc)